Skip to main content
    Overview
    Alternative title
    National Oncology Register
    Acronym
    NOR
    Type of information
    Registry data
    Description

    The purpose of the National Oncology Register (hereinafter referred to as NOR) is the registration of oncological diseases and periodic monitoring of their further development, i.e. data collection, verification, storage, protection and processing. NOR provides summary data for statistical overviews at both national and international levels, as well as for epidemiological studies and health research. NOR is a nationwide population register that follows on from the monitoring of neoplasms in the population of the Czech Republic introduced in the 1950s, and as a population register of records of individual neoplasms, the ÚZIS of the Czech Republic has been operating since 1976.

    NOR data are also used to support early diagnosis and treatment of neoplasms and pre-cancerous conditions, to monitor trends in their occurrence, causative factors and social consequences. At the population level, the results of the treatment of neoplasms are also evaluated in the form of a survival analysis.

    Free keywords
    Cancer registry
    Topics
    Health status » Morbidity/disability » Non-communicable diseases » Cancer
    Country(ies):
    GEO coverage
    Nuts 3
    Sex
    Both
    Data Collection Period
    From 01 January 1976 - Ongoing
    Language(s)
    Czech
    Personal Identifier
    National identifier
    Terms of data access

    Anonymous individual data may be provided for epidemiological studies and medical research in accordance with applicable laws and with the consent of the NOR administrator (ÚZIS CR) and the NOR Council (the expert advisory body of the NOR administrator).

    Data Owner(s)
    Institute of Health Information and Statistics of the Czech Republic
    Contact e-mail
    helpdesk.registry@uzis.cz
    Contact info (address)

    Palackého náměstí 4, PO BOX  60, 128 01  Prague 2
    E-mail: uzis@uzis.cz

    Updated on 28 July 2022